IL6R and COVID-19: Zhang Zhang C C Wu Wu Z Z Li Li JW JW Zhao Zhao H H Wang Wang GQ GQ Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality Int J Antimicrob Agents Int J Antimicrob Agents 2020 2020 55 55 105954 105954 10.1016/j.ijantimicag.2020.105954 10.1016/j.ijantimicag.2020.105954 32234467 32234467